News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The electrical infrastructure supplier reported second-quarter earnings per share of $3.15, with sales of $8.5 billion. Wall Street was looking for EPS of $3.07 and sales of $8.2 billion.
Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.
The tech rebound has legs. Stock futures were rising early Friday as the technology sector looked set to end a bad July on a positive note despite disappointing earnings from Apple. S&P 500 futures rose 0.
Despite plenty of uncertainty on some of the bigger economic issues, Q2 earnings season rolls along quite successfully to this point.
Besides this second quarter, I had the chance to cover Morgan Stanley's note on RTX in April after their impressive Q1. Morgan Stanley cut RTX's price target to $220 but maintained an Overweight rating, viewing the post-earnings dip as a "buying opportunity."Fast forward to this Q2 coverage: RTX ...
The stock is one of the worst performers in the S&P 500 on Thursday, according to Dow Jones Market Data.
BVFL's Q2 earnings per share are aided by higher net interest income, improved margins and reduced borrowing costs, while lower loan balances and softer noninterest income weigh on performance.
Alphabet's huge earnings beat is sending S&P 500 earnings growth soaring.
Mastercard giant posts second-quarter earnings that comfortably top expectations, fueled by growth in its payments network.
Bristol Myers Squibb faces declining revenue in its legacy drug portfolio, but new products like Opdivo are offsetting the drop.
Beer sales volumes are up 1.1% from a year ago, as events like the FIFA World Cup boost sales of Michelob Ultra and other beers.
The stock market sold off as oil prices surged on Trump's Iran threats. Microsoft, Meta and Fortinet were key earnings movers late.
On July 29, 2026, the automaker's adjusted profit of $0.42 per share and higher full-year outlook kept investors focused on margin execution.
AI Stock Rally Faces Reality Check as Earnings Beats Fall Flat
SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.
SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.
GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.
It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.
Ford announced an operating profit of $2.5 billion from sales of $48.3 billion. Things look OK for the U.S. car business.
Options imply a 6.6% move after earnings.
Dillard's currently trades at $573.95 per share and has shown little upside over the past six months, posting a small loss of 4.9%. The stock also fell short of the S&P 500’s 6.3% gain during that period.
